Amgen Inc. (NASDAQ:AMGN) and GSK plc (NYSE:GSK) are reportedly set to announce their partnership with TrumpRx.gov. This collaboration is set to offer substantial discounts on prescription drugs.
This move will augment the total number of discounted prescription medications available on the platform to 54, from five different pharmaceutical companies, according to a report by FOX Business on Friday.
Amgen will offer an 80% discount on Amjevita, a medication used for rheumatoid arthritis, psoriasis, and ulcerative colitis. The drug, originally priced at $1,484, will be available for $299 on TrumpRx.gov. Additionally, Amgen plans to list Aimovig and Repatha for discounts of 62%.
Meanwhile, GSK will offer a 55% discount on Incruse, a medication for COPD, pricing it at $159. The company also plans to list Arnuity, Relenza, and Anoro at discounts ranging from 10% to 51%.
Amgen and GSK did not immediately respond to Benzinga‘s request for comment.
Full story available on Benzinga.com
Reeves to say she will back compulsory purchase powers for Oxford-Cambridge corridor
...
Read moreDetails
